Skip to main content
. Author manuscript; available in PMC: 2011 Jul 19.
Published in final edited form as: Cancer. 2009 Jun 15;115(12):2684–2692. doi: 10.1002/cncr.24335

Table 2. Association of EphA2 overexpression with clinicopathologic variables in endometrioid endometrial cancer.

N=139***

Low EphA2 High EphA2 p
Stage Low (I/II) 61 47
High (III/IV) 10 19 0.04
Grade Low (1 or 2) 65 47
High (3) 6 19 0.003
Depth of invasion ≤ 1/2 56 42
> 1/2 15 24 0.047
Node status Negative 40 34
Positive 25 24
Not done 6 8 0.7
ER* Low 28 41
High 43 25 0.01
PR* Low 23 37
High 48 29 0.006
Ki-67** Low 48 33
High 23 33 0.04

NOTE:

*

Low expression of ER and PR denotes negative, weak or moderate expression (SI = 0-8); high expression of ER and PR denotes strong expression (SI = 9-12).

**

Low expression of Ki-67 denotes ≤ 30% positive cells and high expression denotes > 30% positive cells.

***

Missing numbers denote samples that were damaged and could not be evaluated.